FDA Approves Truvada to Help Prevent HIV Infection
(page 1 of 4) View Entire Story
The U.S. Food and Drug Administration approved Monday a Gilead Sciences Inc. (GILD) HIV drug for use in certain healthy people to help prevent them from contracting the virus that causes AIDS, marking a milestone in the three-decade effort to prevent HIV and AIDS.

Truvada was previously approved for use in combination with other drugs to treat HIV. The new approval marks the first time the FDA has approved a drug to prevent HIV infection. The approval allows Truvada to be used in people who are considered at high risk of becoming infected with HIV, such as those who have an HIV-infected partner.

The FDA said Truvada, a pill taken daily, is to be used in combination with safe-sex practices, such as condom use, to cut the risk of sexually acquired HIV infection in adults. The agency said doctors need to test patients to make sure they are HIV-negative before prescribing Truvada and do follow-up testing every three months. The use of Truvada alone in a person who might become infected with HIV won't treat the virus effectively.


Next Page
More Latest News
 
DOW up 8.60 | NAS down 0.28 | S&P down 0.91
(Data as of 2013-05-24 4:35 EDT)
 SEARCH: